Join IQVIA and Salutem Insights for a breakfast briefing on Real World Evidence in Market Access — exploring how RWE is transforming access pathways for obesity, orphan, and oncology medicines.

On Wednesday, 8 October 2025, Sandra Redmond, Managing Director at Salutem Insights, and Gwynne Morley, General Manager at IQVIA Ireland, will lead an in-person session at the Clayton Hotel Liffey Valley, Dublin.

The discussion will highlight how real world evidence is increasingly critical to securing reimbursement and shaping market access strategies. By going beyond clinical trial data, RWE can address payer expectations, demonstrate value, and support more equitable healthcare delivery.

Key themes include:

• Obesity medicines: leveraging real world outcomes to accelerate access in a fast-moving therapeutic area.

• Orphan medicines: tackling the evidence challenges of rare diseases with small patient populations.

• Oncology medicines: showing how data-driven insights are reshaping reimbursement pathways in one of the most competitive therapy areas.

• Strategic partnerships: how collaboration between consultancies and life sciences companies drives actionable evidence.

This event is designed for professionals involved in pricing, reimbursement, policy, and market access who want practical insights into applying RWE to optimise strategy.

📅 Date: Wednesday, 8 October 2025

🕗 Time: 08:00 – 09:30 BST
📍 Venue: Clayton Hotel, Liffey Valley, Dublin

👉 Register now to secure your place: Book Here